Screening for Distress in Patients with Cancer: Methodologic Considerations
Abstract
Share and Cite
Feldstain, A.; Tomei, C.; Bélanger, M.; Lebel, S. Screening for Distress in Patients with Cancer: Methodologic Considerations. Curr. Oncol. 2014, 21, 330-333. https://doi.org/10.3747/co.21.1794
Feldstain A, Tomei C, Bélanger M, Lebel S. Screening for Distress in Patients with Cancer: Methodologic Considerations. Current Oncology. 2014; 21(2):330-333. https://doi.org/10.3747/co.21.1794
Chicago/Turabian StyleFeldstain, A., C. Tomei, M. Bélanger, and S. Lebel. 2014. "Screening for Distress in Patients with Cancer: Methodologic Considerations" Current Oncology 21, no. 2: 330-333. https://doi.org/10.3747/co.21.1794
APA StyleFeldstain, A., Tomei, C., Bélanger, M., & Lebel, S. (2014). Screening for Distress in Patients with Cancer: Methodologic Considerations. Current Oncology, 21(2), 330-333. https://doi.org/10.3747/co.21.1794